Brent Cliveden

PhD, BSc (Hons), AB

Chief Scientific Officer and Co-Founder

Brent has strong international experience encompassing clinical research, consulting, product management, business development, marketing, and account management.  

He has worked with various entities in the health tech industry. These include top-10 pharmaceuticals, biotech and medical device companies, contract research organizations (CROs), academic medical research centers, the NIH, and NHS Trusts in the UK. 

Ivy League-educated and trained, he possesses a deep knowledge of hemostasis and thrombosis, gained through 12 years of experience in biomedical, clinical, pre-clinical, and basic research. In addition, he had held a post-doctoral fellowship and co-investigator positions in the UK and US. 

His contributions to the science literature include multiple published papers which include a definitive review of "Platelet metabolism and the effect of drugs.” This appeared as a chapter in the book Hematology, vol 2, Hemostasis and Thrombosis, published by Butterworths Ltd.  

He is an adept leader with experience in managing teams and coordinating efforts across international organizations and departments.  

© 2024 Emerald Venture Partners. All Rights Reserved.
Site by The Dott.
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram